Join
Live feed
·
INSIDERFilingvia Quantisnow
Korro Bio Inc. logo

Senior Vice President, Finance Dolan Oliver sold $69 worth of shares (5 units at $13.72) as part of a pre-agreed trading plan, decreasing direct ownership by 0.03% to 16,241 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KRRO· Korro Bio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRRO (Korro Bio Inc.) and more on Quantisnow.